Page 63 - JSOM Summer 2025
P. 63

Evaluation System (DES) to determine if they are amenable   2.  de Loizaga SR, Arthur L, Arya B, et al. Rheumatic heart disease
                                     16
              for continued military service.  Most will undergo a medical   in the United States: forgotten but not gone: results of a 10 year
              evaluation board process with subsequent medical retirement.  multicenter review. J Am Heart Assoc. 2021;10(16):e020992. doi:
                                                                    10.1161/JAHA.120.020992
                                                                 3.  Salman  A, Larik MO,  Amir MA, et al.  Trends in rheumatic
              Conclusion                                            heart disease-related mortality in the United States from 1999
                                                                    to 2020. Curr Probl Cardiol. 2024;49(1):102148. doi:10.1016/j.
              RHD is rare within the SOF population but may cause sig-  cpcardiol.2023.102148
              nificant morbidity and potential mortality if unidentified and   4.  Sika-Paotonu D, Beaton A, Raghu A, Steer A, Carapetis J. Acute
              untreated. While recognition and treatment of streptococcal   rheumatic fever and rheumatic heart disease. In: Ferretti JJ, Ste-
              infection attempt to combat this disease process, autoim-  vens DL, Fischetti VA, eds. Streptococcus pyogenes: Basic Biology
              mune destruction can generate MS or MR. Patients present   to Clinical Manifestations. University of Oklahoma Health Sci-
                                                                    ences Center; 2016.
              with chronic and progressive dyspnea, orthopnea, syncope or   5.  Simpson MT, Kachel M, Neely RC, et al. Rheumatic heart dis-
              near-syncope, and exercise intolerance; in the SOF population,   ease in the developing world.  Struct Heart. 2023;7(6):100219.
              decreased exercise tolerance from their typically high baseline   doi:10.1016/j.shj.2023.100219
              of physical fitness may be particularly noticeable. A thorough   6.  Perone F, Peruzzi M, Conte E, et al. An overview of sport partici-
              workup may demonstrate non-specific ECG changes and po-  pation and exercise prescription in mitral valve disease. J Cardio-
                                                                    vasc Dev Dis. 2023;10(7):304. doi:10.3390/jcdd10070304
              tential  dysrhythmia,  though diagnosis  is  confirmed  with  a   7.  Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guide-
              TTE. Heart failure can be managed conservatively while the   line for the diagnosis and management of group A streptococcal
              severity of mitral valvular disease will dictate if further inter-  pharyngitis: 2012 update by the Infectious Diseases Society of
              vention is indicated. SOF medics and providers should main-  America. Clin Infect Dis. 2012;55(10):e86–102. doi:10.1093/cid/
              tain a high level of clinical suspicion in those complaining of   cis629
              dyspnea, near-syncope or syncope, and decreased exercise tol-  8.  Passos LSA, Nunes MCP, Aikawa E. Rheumatic heart valve dis-
              erance to ensure timely diagnosis and treatment of this rare   ease pathophysiology and underlying mechanisms. Front Cardio-
                                                                    vasc Med. 2021;7:612716. doi:10.3389/fcvm.2020.612716
              but potentially life-threatening condition.        9.  Cunningham MW. Rheumatic fever, autoimmunity, and molec-
                                                                    ular mimicry: the streptococcal connection.  Int Rev Immunol.
              Author Contributions                                  2014;33(4):314–329. doi:10.3109/08830185.2014.917411
              KO, DD, AC, and RB generated the manuscript. MM provided   10.  Reményi B,  Wilson N, Steer  A, et al.  World Heart Federation
              care for the patient and provided edits. All authors approved   criteria for echocardiographic diagnosis of rheumatic heart dis-
              the final draft.                                      ease—an evidence-based guideline. Nat Rev Cardiol. 2012;9(5):
                                                                    297–309. doi:10.1038/nrcardio.2012.7
                                                                 11.  Kumar RK, Antunes MJ, Beaton A, et al. Contemporary diagno-
              Disclaimer                                            sis and management of rheumatic heart disease: implications for
              The view(s) expressed herein are those of the author(s) and   closing the gap: a scientific statement from the American Heart
              do not reflect the official policy or position of Madigan Army   Association. Circulation. 2020;142(20):e337–e357. doi:10.1161/
              Medical Center, the U.S.  Army Medical Department, U.S.   CIR.0000000000000921
              Army Special Operations Command, the U.S. Army Office of   12.  Karthikeyan G, Ntsekhe M, Islam S, et al. Mortality and morbidity
              the Surgeon General, the Department of the Army, the Depart-  in adults with rheumatic heart disease. JAMA. 2024;332(2):133.
                                                                    doi:10.1001/jama.2024.8258
              ment of the Navy, the Department of the Air Force, Uniformed   13.  Shah SN, Sharma S. Mitral stenosis. In: StatPearls. StatPearls Pub-
              Services University of the Health Sciences, Department of De-  lishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK430742/
              fense, or U.S. Government.                         14.  Dougherty S, Okello E, Mwangi J, Kumar RK. Rheumatic heart
                                                                    disease. J Am Coll Cardiol. 2023;81(1):81–94. doi:10.1016/j.jacc.
              Disclosures                                           2022.09.050
              The authors have nothing to disclose.              15.  Otto CM, Nishimura RA, Bonow RO, et al.  2020 ACC/AHA
                                                                    guideline for the management of patients with valvular heart
                                                                    disease: executive summary: a report of the American College
              Funding                                               of Cardiology/American Heart Association Joint Committee on
              No funding was received for this work.                Clinical Practice Guidelines.  Circulation. 2021;143(5). doi:10.
                                                                    1161/CIR.0000000000000932
              References                                         16.  Medical Services Department of the Army. Army Regulation 40-
              1.  Hu Y, Tong Z, Huang X, et al. The projections of global and re-  501 – standards of medical fitness. In: Standards of Medical Fit-
                gional rheumatic heart disease burden from 2020 to 2030. Front   ness. 2019.
                Cardiovasc Med. 2022;9:941917. doi:10.3389/fcvm.2022.941917
                                                                 PMID: 40504704; DOI: 10.55460/HXSI-RCVU




















                                                                             RHD and Valve Placement in an SOF Soldier  |  61
   58   59   60   61   62   63   64   65   66   67   68